DEVELOPMENT OF VACCINE

Hyderabad's IIL develops live-attenuated vax for Covid-19

​Pointing out that live attenuated vaccines generate a robust and broad-spectrum neutralising antibody response, IIL said its needle-free intra-nasal Covid-19 booster vaccine had demonstrated "remarkable stability and maintained safety in extensive animal studies." The vaccine has been developed using codon deoptimisation technology.